GB823155A - Improvements in or relating to packages for capsules - Google Patents
Improvements in or relating to packages for capsulesInfo
- Publication number
- GB823155A GB823155A GB7510/56A GB751056A GB823155A GB 823155 A GB823155 A GB 823155A GB 7510/56 A GB7510/56 A GB 7510/56A GB 751056 A GB751056 A GB 751056A GB 823155 A GB823155 A GB 823155A
- Authority
- GB
- United Kingdom
- Prior art keywords
- propionate
- hydrocortisone
- polyethylene glycol
- neomycin
- corticorteroids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002775 capsule Substances 0.000 title 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 6
- 229960000890 hydrocortisone Drugs 0.000 abstract 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 abstract 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 abstract 1
- OMSBSIXAZZRIRW-UHFFFAOYSA-N 2-methylpyridine;hydrochloride Chemical compound Cl.CC1=CC=CC=N1 OMSBSIXAZZRIRW-UHFFFAOYSA-N 0.000 abstract 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 abstract 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 abstract 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 abstract 1
- 108010026389 Gramicidin Proteins 0.000 abstract 1
- 229930193140 Neomycin Natural products 0.000 abstract 1
- 239000004100 Oxytetracycline Substances 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 239000004264 Petrolatum Substances 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 108010021006 Tyrothricin Proteins 0.000 abstract 1
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- ZZKLBPLJHJQUJL-UHFFFAOYSA-N benzoic acid;propanoic acid Chemical compound CCC(O)=O.OC(=O)C1=CC=CC=C1 ZZKLBPLJHJQUJL-UHFFFAOYSA-N 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- ZBPLOVFIXSTCRZ-UHFFFAOYSA-N bromfenac Chemical compound NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1 ZBPLOVFIXSTCRZ-UHFFFAOYSA-N 0.000 abstract 1
- 229960003655 bromfenac Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960005091 chloramphenicol Drugs 0.000 abstract 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
- 239000000084 colloidal system Substances 0.000 abstract 1
- 229960004544 cortisone Drugs 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 abstract 1
- 229960004905 gramicidin Drugs 0.000 abstract 1
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 abstract 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 abstract 1
- 229910052753 mercury Inorganic materials 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 229960004927 neomycin Drugs 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000003883 ointment base Substances 0.000 abstract 1
- 229960000625 oxytetracycline Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract 1
- 235000019366 oxytetracycline Nutrition 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 229940066842 petrolatum Drugs 0.000 abstract 1
- 235000019271 petrolatum Nutrition 0.000 abstract 1
- QXDAEKSDNVPFJG-UHFFFAOYSA-N phenacaine Chemical compound C1=CC(OCC)=CC=C1N\C(C)=N\C1=CC=C(OCC)C=C1 QXDAEKSDNVPFJG-UHFFFAOYSA-N 0.000 abstract 1
- 229950007049 phenacaine Drugs 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 abstract 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 abstract 1
- WQVJHHACXVLGBL-GOVYWFKWSA-N polymyxin B1 Polymers N1C(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)CCCC[C@H](C)CC)CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1CC1=CC=CC=C1 WQVJHHACXVLGBL-GOVYWFKWSA-N 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 abstract 1
- 239000004324 sodium propionate Substances 0.000 abstract 1
- 235000010334 sodium propionate Nutrition 0.000 abstract 1
- 229960003212 sodium propionate Drugs 0.000 abstract 1
- 239000004334 sorbic acid Substances 0.000 abstract 1
- 235000010199 sorbic acid Nutrition 0.000 abstract 1
- 229940075582 sorbic acid Drugs 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 abstract 1
- 229960004306 sulfadiazine Drugs 0.000 abstract 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 abstract 1
- 229960001544 sulfathiazole Drugs 0.000 abstract 1
- -1 sulphaacetamide Chemical compound 0.000 abstract 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- GSXRBRIWJGAPDU-BBVRJQLQSA-N tyrocidine A Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 GSXRBRIWJGAPDU-BBVRJQLQSA-N 0.000 abstract 1
- 229960003281 tyrothricin Drugs 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
- 210000002268 wool Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical ointments and creams comprise hydrocortisone and neomycin sulphate in a wool fat petrolatum base, or hydrocortisone and neomycin sulphate in an aqueous base containing sodium citrate, polyvinyl pyrrolidone, myristyl, picolinium chloride and polyethylene glycol. The hydrocortisone may be replaced in toto or in part by cortisone or other 11 oxygenated corticorteroids. In place of the acetates of the 11 oxygenated corticorteroids there may be used other esters thereof such as propionate benzoate, stearate, a - or b -cyclopentyl propionate, furoate, penylacetate, a - or b -phenyl propionate, and b -furyl-acrylate. The neomycin may be replaced in part or in toto by (a) other antibiotics such as bacatricin, polymycin B, chloramphenicol, tetracycline, oxytetracycline, streptomycin, penicillin, tyrothricin, erythromycin, and gramicidin, and (b) antibacterials such as sodium propionate, sorbic acid, methyl and propyl R-hydroxybenzoate, boric acid, sulphaacetamide, sulphadiazine, sulphathiazole, orthohydroxy-phenylmercuric chloride and yellox oxide of mercury. In addition there can be added local an sthetics such as phenacaine. Other ointment bases or vehicles such as polyethylene glycol 400 U.S.P. 30 grams, polyethylene glycol 1500, 200 grams, and other dispensing agents such as methylcellulose, alginates and like protective colloids, may be used. U.S.A. Specification 2,667,268 is referred to.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US823155XA | 1955-03-21 | 1955-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB823155A true GB823155A (en) | 1959-11-04 |
Family
ID=22170439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB7510/56A Expired GB823155A (en) | 1955-03-21 | 1956-03-09 | Improvements in or relating to packages for capsules |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB823155A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8882736B2 (en) | 2005-07-01 | 2014-11-11 | Norton Healthcare Limited | Container for resuspending sedimented medicament |
-
1956
- 1956-03-09 GB GB7510/56A patent/GB823155A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8882736B2 (en) | 2005-07-01 | 2014-11-11 | Norton Healthcare Limited | Container for resuspending sedimented medicament |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7507268A (en) | PROCESS FOR THE PREPARATION OF 1 (ALPHA), 24-DIHYDROXY-CHOLE-CALCIFEROLS, AS WELL AS DERIVATIVES AND PREPARATIONS THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS ACTIVE COMPONENTS. | |
| GB983130A (en) | Improvements in preparations for the removal of wax from the ear | |
| HU173557B (en) | Process for producing 3-amino-indazolecarboxylic acid derivatives and pharmaceutical compositions containing the as active agents | |
| GB823155A (en) | Improvements in or relating to packages for capsules | |
| GB1015787A (en) | Tris-(p-methoxyphenyl)ethylene derivatives | |
| GB1212704A (en) | Vaginal suppositories | |
| GB1016959A (en) | Substituted steroid hormones | |
| NL7509032A (en) | PROCESS FOR PREPARING SUBSTITUTED 2H-PYRANE-2,6 (3H) -DION DERIVATIVES, AND OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| NL7504577A (en) | PROCESS FOR PREPARING 6-AZIDO-4,6-PREG-NADIENO (3.2-C) PYRAZOLES AND PHARMA-CEUTIC PREPARATIONS CONTAINING THESE COMPONENTS AS ACTIVE COMPONENTS. | |
| NL7608319A (en) | PROCESS FOR THE PREPARATION OF 1,2,3,4-TETRAHYDROISOQUEINOLINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT. | |
| CA484048A (en) | Veterinary medicinal agent | |
| GB1267514A (en) | Improvements relating to artificial insemination of pigs | |
| NL139980B (en) | PROCESS FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DERIVATIVES OF CEPHALOSPORIN C AND OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES. | |
| JPS52154654A (en) | Process status indicator | |
| GB1233150A (en) | ||
| CA549541A (en) | Compositions containing diacylaminodiphenyldisulfide plasticizers, clay and dispersing agent | |
| GB1145393A (en) | Improvements in or relating to 17-‡-(alka-1',3'-diynyl)-steroids | |
| AU272552B2 (en) | A novel therapeutically active gonadiene, process for its preparation and pharmaceutical compositions thereof | |
| GB1429951A (en) | O-nitroaryl-oximes of 3-keto steroids | |
| GB839376A (en) | Steroid compounds and their preparation | |
| GB1262585A (en) | Improvements in or relating to quaternary ammonium steroids | |
| CA541788A (en) | Apparatus for the extrusion of thin-walled seamless tubes of thermoplastic materials | |
| AU268742B2 (en) | 1,2,3,4,5,7-HEXAHYDRO-11b-H-BENZOPYRIDOCOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| AU246698B2 (en) | Instrument for fluid injections into the uterus and fallopian tubes | |
| CA477700A (en) | Drain-clear containers for aqueous-vehicle liquid pharmaceutical preparations |